Celltex News
Aging & Disease Reports Transplantation of ACE2- Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia
The COVID-19 pandemic has the global medical profession working around the clock looking for vaccines and therapies.
The journal Aging & Disease has recently reported on a study that has proven transplantation of mesenchymal stem cells has improved the outcome of 7 patients diagnosed with COVID-19 Pneumonia in Bejing, China. Celltex is continuing to monitor this effective research.
If you currently have your MSCs banked at Celltex and are wondering what options are available to you, please contact the Client Services team today by completing the form on our Request a Consultation page, by calling (713) 590-1000 or sending an email to info@celltexbank.com. If you are not a client but would like to bank your MSCs, please complete our online client assessment and a Client Services Coordinator will contact you.
More Recent News
Physician Panel on Stem Cell Therapy: Advanced Techniques in Regenerative Medicine
Celltex hosted a webinar with a panel of guest speakers that included esteemed, licensed physicians at Hospital Galenia in Cancun who have been working with Celltex Mexico for over a decade and who have extensive experience in regenerative medicine.
In this article, we’ll describe some of the key details from the panel discussion, specifically relating to the stem cell therapy process, its many clinical applications, and an in-depth look at several advanced regenerative medicine techniques.
Read MoreAn Introduction to Stem Cells & Stem Cell Therapy
Regenerative medicine research has been around for quite some time, yet some may still lack a clear understanding of what stem cells are and what their capabilities are.
In this article, we explore the different types of stem cells, where they can be found in the body, and what their potential applications are.
Read More